Sponsor or institution
Clinical trials and research at Virtus Therapeutics Corporation
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $1.4 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
PanK Activators to Help Panthothenate Kinase-Associated Neurodegeneration (PKAN)
A new project is testing tiny molecules that could boost a key cellular helper (CoA) to slow or treat PKAN, a rare childhood neurodegenerative disease.
-
Activating a specific enzyme to treat a rare neurodegenerative disorder
This study is looking for a way to help people with PKAN, a rare brain disorder, by finding a treatment that boosts a specific enzyme in their cells to improve their health.
-
Activating a specific enzyme to treat a rare neurodegenerative disorder
This study is looking for a way to help people with pantothenate kinase-associated neurodegeneration (PKAN) by finding new treatments that can boost a specific enzyme in their cells, which might help fix some of the problems caused by the disease.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.